Weston Brain Institute Transformational Research 2018 - Neurodegenerative Diseases of Aging

The Weston Brain Institute supports translational research to accelerate the development of therapeutics for neurodegenerative diseases of aging. We are pleased to launch the Transformational Research: Canada 2018 program. 

Program Goal

To provide funding for translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging.

New for 2018

  1. Translational research using humans or human samples/data is in scope, except for clinical trials or clinical trial sub-studies which should be submitted to the Early-Phase Clinical Trials or Rapid Response programs.
  2. The Institute has updated which tools are in scope. Please see below and read our What We Fund webpage before applying to ensure your project is in scope.
     
Funding 

A maximum of $1,500,000 over up to 3 years.

Important Dates
  • Program Information Webinar: October 25th, 2017 at 1pm EDT (Register here)
  • Letter of Intent Deadline: December 7th, 2017 at 2pm EDT
  • Anticipated Award: August 2018
Program Announcement 

The Institute’s Postdoctoral Scholars at Oxford program is now open to applicants year-round. Canadian postdoctoral researchers working in the field of translational research on neurodegenerative diseases of aging may apply to receive up to £57,000 in funding (£44,000 salary + benefits) for research performed in a host lab at the University of Oxford. Successful candidates will also be affiliated with Merton College. For more information, visit our website or contact Rachel Reeve at rachel.reeve@weston.ca.

 

 

 

Application Procedures

Eligibility Summary

Applicant Eligibility

Eligible Principal Applicants must be researchers working in Canada at least 30% of the time at or above the level of Assistant Professor or equivalent, and be affiliated with a Canada Revenue Agency-qualified donee institution located in Canada. Co-Applicants/Collaborators must be at the post-doctoral level or above and can be working outside Canada.

Project Eligibility 

Projects must meet the following conditions to be eligible:

  1. Be translational research, excluding clinical trials and clinical trial sub-studies, that accelerates the development of therapeutics for neurodegenerative diseases of aging.
  • Clinical trials and clinical trial sub-studies should be submitted to the Early-Phase Clinical Trials or Rapid Response programs; however other translational research using humans or human samples/data is in scope.
  1. Be the development of a therapeutic and/or tool.
  2. Have excellent preliminary data to support the proposed project.

 

Evaluation Criteria

Disease Scope 

All the Institute’s neurodegenerative diseases of aging are covered by this program (see What We Fund page).

Development Scope

Development of a therapeutic and/or a tool that helps to accelerate the development of therapeutics for neurodegenerative diseases of aging.

Deadline

Thursday, 7 December 2017

Annual Value

A maximum of $1,500,000 over up to 3 years.